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SUMMARY
Purpose: Convulsive status epilepticus (CSE) is the most
common pediatric neurologic emergency and is often
associated with unfavorable neurodevelopmental out-
comes. The early developmental trajectory of children
following CSE has not been previously investigated, leav-
ing a gap in our understanding of how these adverse long-
term outcomes emerge.
Methods: We prospectively recruited children aged
between 1 and 42 months from a predefined geographic
region of North London who had at least one episode of
CSE and classified them as prolonged febrile seizures (PFS)
or nonfebrile CSE. Neuropsychological and imaging investi-
gations were conducted within 6 weeks of CSE (baseline)
and were repeated a year later (follow-up). Neurodevelop-
ment was assessed using the Bayley Scales of Infant Devel-
opment III and compared to normally developing children.
Predictors of neurodevelopmental scores at baseline and
follow-up were investigated using regression analyses.
Key Findings: Of the 54 children that underwent investi-
gations a mean of 38 days following CSE, 27 had PFS
(mean age 18.4 months) and 27 had nonfebrile CSE
(mean age 15.5 months). In addition, 17 healthy controls
were assessed (mean age 20.49 months). Children with
nonfebrile CSE had a worse developmental outcome than
children with PFS (p < 0.002), despite there being no
differences in seizure characteristics. In contrast to
expectations, the PFS group had a worse developmental
outcome than controls (p = 0.002). There were no signifi-
cant differences in performance from baseline to 1-year
follow-up for the 70.4% of children who provided data.
Seizure characteristics were not shown to be significant
predictors of performance.
Significance: CSE is associated with developmental
impairments within 6 weeks of the acute event that con-
tinue to be present a year onward. This is also true of PFS
cases that under-perform relative to controls despite
mean scores within the clinically normal range. The
absence of a change in performance from baseline to
follow-up as well as the lack of a relationship between
seizure characteristics and developmental outcomes
supports the notion that premorbid abilities may be over-
shadowing any direct effects of CSE itself on outcome.
KEY WORDS: Prolonged febrile seizures, Developmen-
tal outcomes, Cognition, Language.
Convulsive status epilepticus (CSE), the most common
pediatric neurologic emergency (DeLorenzo et al., 1995), is
associated with significant mortality and morbidity
(Raspall-Chaure et al., 2006). The incidence of CSE is
highest within the first 3 years of life (Chin et al., 2006), a
period during which critical developmental events occur
(Committee on Integrating the Science of Child Develop-
ment, 2000). Early neurologic insults are associated with
worse longer term outcomes in retrospective studies (Riney
et al., 2006; Cormack et al., 2007; Scott, 2010), and animal
studies have shown that enriching an animal’s environment
can modulate the degree of functional impairments follow-
ing CSE in the longer term (Rutten et al., 2002). Therefore,
it is imperative to assess the effects of CSE in children soon
after CSE to determine their developmental status and
examine whether intervention is warranted.
Most studies investigating the consequences of CSE to
date: (1) have focused on simple febrile seizures and have
included a subsample of children with prolonged febrile
seizures (PFS), a type of CSE, within their study sample
(Schiottz-Christensen & Bruhn, 1973; Nelson & Ellenberg,
1978; Hesdorffer et al., 2011), (2) have been conducted sev-
eral years following CSE (Nelson & Ellenberg, 1978; Verity
et al., 1985, 1993; K€olfen et al., 1998), and (3) have been
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performed without the use of standardized neuropsycholog-
ical instruments (Aicardi & Chevrie, 1970; van Esch et al.,
1996). The aims of the current study were the following: (1)
to investigate cognitive, language, and motor functions in
children within 6 weeks of CSE and a year later to deter-
mine their developmental trajectories; and (2) to identify
risk factors for poor outcomes at baseline (within 6 weeks)
and follow-up (1 year later). PFS, which occur in children
with normal development, were investigated separately
from those with nonfebrile CSE, who often have previous
neurologic abnormalities.
Methods
Participants
We prospectively recruited children aged 1–42 months
who had at least one episode of CSE between December
2006 and March 2010. Patients were recruited from north
London hospitals using a recruitment strategy similar to
the North London Convulsive Status Epilepticus Surveil-
lance study (Chin et al., 2006), which is described in detail
elsewhere (Yoong et al., 2012). In brief, we collected
baseline clinical data and arranged for the child to have a
magnetic resonance imaging (MRI) scan and neuropsycho-
logical assessments at University College London Institute
of Child Health (ICH)/Great Ormond Street Hospital
(GOSH) at the parents’ earliest convenience. When
patients attended GOSH for their brain MRI, a clinical his-
tory was taken by MY from each family, which included
the following: medical history; seizure semiology; and any
concerns about development prior to CSE. Participating
families in our patient population were invited back a year
later for repeat assessments.
We also recruited control participants of a similar age
range in whom parents or caregivers had no concerns about
development prior to the assessment and who had no previ-
ous history of provoked or unprovoked seizures. Control
participants were recruited via parenting groups, cinema
screenings for mothers and their babies, and through
acquaintances with children in that age range. Dizygotic
twin siblings of two PFS infants were also assessed, and
their results are reported separately from those of other con-
trol participants. Control participants were only seen once
during our study. Indices of multiple deprivation (IMDs)
were calculated for all participants (http://www.ons.gov.uk)
and used as proxy measure for individual socioeconomic
status (SES). IMD scores are calculated on the basis of
home address postal codes and comprise seven separate
dimensions of deprivation (income, employment, health,
education, housing, crime, and living environment) the
individual scores of which have been standardized and
combined in a weighted manner to make a single score for
the smallest socially homogenous local area. Increasing
scores correlate with worsening SES (Office of the Deputy
PrimeMinister, 2007).
Operational definitions
CSE was defined as a tonic, clonic, or tonic–clonic
seizure (continuous), or two or more seizures between
which consciousness was not regained (intermittent), which
lasted for at least 30 min. Seizure duration was estimated
from the initial referral report and corroborated by parental
recollection. Two pediatric neurologists (RCS and RFMC)
independently reviewed each case and classified the chil-
dren into two groups: a PFS group and a nonfebrile CSE
group. PFS was defined as CSE in an otherwise neurologi-
cally normal child from the age of 6 months with a fever
(temperature of  38°C) (International League Against
Epilepsy, 1993). The nonfebrile CSE group included the
following five etiologic groups as defined in our previous
studies (Chin et al., 2006): (1) acute symptomatic (AS), (2)
remote symptomatic (RS), (3) idiopathic epilepsy related
(IER), (4) cryptogenic epilepsy related (CER), and, (5)
unclassified CSE (UN). Any differences in opinion were
resolved by consensus discussion.
Neurodevelopmental assessments
A neuropsychologist (MM) blinded to medical details
and patient classification carried out the assessments.
Infants were assessed using the Bayley Scales of Infant and
Toddler Development (3rd edition; Bayley, 2005). The Bay-
ley scales provide three normative composites with a mean
of a 100 and a standard deviation of 15: cognitive, language
and motor composites. When necessary, the Bayley com-
posite scores were corrected for prematurity.
Magnetic resonance imaging
MRI investigations were carried out in a Siemens Avanto
1.5 T (Erlangen, Germany) whole body system using stan-
dard epilepsy protocol imaging. The images were reviewed
by two experienced pediatric neuroradiologists (WKC and
RG) blinded to the patient’s medical history who agreed by
consensus whether the scan contained no abnormalities,
minor abnormalities, or major abnormalities. A minor
abnormality was defined as an abnormal feature thought to
be either unrelated to this episode of CSE or of no functional
significance. A major abnormality was defined as an abnor-
mal feature likely to have significant effect on the child
and/or represent a cause for this episode of CSE.
Ethics
The study was approved by the ICH/GOSH Research
Ethics Committee. Local Research and Development regis-
tration was obtained at all referring hospitals. Written
informed consent to participate in the study was obtained
from all parents at the initial assessment.
Statistical analyses
Analysis was done with Predictive Analytics Software
(PASW) version 18 (Chicago, IL, U.S.A.) for Windows. A
p-value of 0.05 was used as the cut-off point for statistical
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significance. We defined our first assessment post CSE as
our baseline assessment. Comparisons of group characteris-
tics were made using chi-square analyses, independent sam-
ple t-tests, and one way analysis of variance (ANOVA). To
reduce our dataset, we ran a principal component analysis
(PCA) on the Bayley composites that derived one factor
with an eigenvalue larger than 1. We subsequently ran a uni-
variate ANOVA on the derived factor to detect any differ-
ences in performance between the PFS, the nonfebrile CSE,
and the control groups, controlling for age in months, gen-
der, prematurity (<36 weeks of gestation), English as a first
language (yes or no), and SES.
To investigate our primary hypothesis, that is, that seizure
characteristics per se predict outcomes after CSE, we ran a
univariate ANOVA on the PCA-derived factor for the two
patient groups combined. Seizure duration, days elapsed
from CSE, focality of seizure (generalized or focal), and
type of seizure (continuous or intermittent) were included in
our model. To investigate our secondary hypothesis, that is,
that prior neurologic insults predict outcomes after CSE we
ran a univariate ANOVA on the PCA-derived factors for the
two patient groups combined where we included age at
assessment, prematurity, previous occurrence of CSE (yes
or no), previous occurrence of short seizures (yes or no),
and MRI abnormalities (normal, minor, major),. For the
follow-up data, paired sample t-tests were carried out to
measure significant changes in performance from baseline
to follow-up. Pearson’s correlations were conducted to
investigate relationships between baseline and follow-up
composites. Finally, regression analyses were performed to
determine predictors of neurodevelopmental outcome in our
two patient groups. Bootstrapping based on 1,000 samples
was applied to all our analyses.
Results
Baseline
One hundred fifty-one infants were referred during our
recruitment period. From these, 54 parents agreed to take
part in the study. The remaining CSE patients were not
assessed for one of the following reasons: (1) families were
noncontactable (N = 25), (2) patients were not suitable for
sedation (N = 10), (3) parents declined participation
(N = 43), (4) families lived far from the study center
(N = 10), (5) patients died prior to recruitment (N = 7), (6)
one family agreed to participate but never attended (N = 1),
and (7) one family only spoke Tamil (N = 1). No differ-
ences in age (p = 0.478), gender (p = 0.600), SES
(p = 0.759), or duration of seizure (p = 0.146) were present
between the participating and the nonparticipating sample.
However, the distribution of causes within the nonfebrile
CSE group was found to be significantly different between
the participating and the nonparticipating samples (cause
was identifiable in 84 out of 97 nonparticipants; v2 = 14.65,
p = 0.012). This difference was driven by a larger propor-
tion of acute symptomatic cases in the nonparticipating
sample.
Table 1 provides the clinical and demographic characteris-
tics of the study population. Children were assessed a mean
of 38 days post CSE (mean duration 75.4 min). Twenty-
seven infants had PFS and 27 children had nonfebrile CSE.
Three children with a confirmed SCN1A mutation were
included in the nonfebrile CSE group as their CSE was pre-
ceded by afebrile seizures. There were no differences
between the two patient groups in seizure characteristics.
These included age at CSE (p = 0.203), duration
(p = 0.207), time from seizure (p = 0.180), proportion of
Table 1. Clinical and demographic information for the PFS, the nonfebrile CSE, and the control groups
PFS Nonfebrile CSE Controls
N 27 27 17
Male 9 18 7
Age at test in months (SD) 18.41 (6.92) 15.46 (9.63) 20.49 (10.38)
Indices of mean deprivation (SD) 29.5 (14.42) 25.16 (12.39) 30 (13.11)
English as a first language 10 21 17
Prematurity 4 6 1
Parental report of developmental problems prior to CSE 6 12 0
MRI abnormalities (major/minor/N of scans) 0/0/26 8/4/24 0/0/5
Antiepileptic drugs 1 19 N/A
Days from CSE (range) 46.5 (10–254) 30.2 (6–66) N/A
Previous seizures 9 20 N/A
Previous CSE 1 11 N/A
Diagnosis of epilepsy 0 19 N/A
Continuous CSE 15 16 N/A
Focal onset of CSE 4/26 7/27 N/A
Duration of CSE in min (SD) 82.70 (37.28) 68.03 (48.23) N/A
Cognitive composite (SD) 92.59 (13.82) 74.44 (19.43) 107.35 (16.87)
Language composite (SD) 90.96 (16.01) 75.30 (20.49) 113.59 (18.77)
Motor composite (SD) 95.70 (13.03) 77.04 (22.32) 103.18 (10.44)
SD, standard deviation; PFS, prolonged febrile seizures; CSE, convulsive status epilepticus; N, number; N/A, not applicable.
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generalized versus focal onset of CSE (p = 0.321), and
proportion of continuous versus intermittent CSE (p = 1).
Proportion of developmental concerns prior to CSE was
similar in both patient groups (p = 0.232). Nevertheless,
the type of developmental delay reported for the two
groups was dissimilar in the severity of the reported symp-
toms, with the most frequently reported symptom in the
PFS group being that of speech delay. Table S1 lists the
kinds of developmental delay reported by parents as well
as the results from our neuropsychological assessments for
each of these cases.
Children with nonfebrile CSE were more likely to have
an MRI abnormality with no visibly apparent MRI abnor-
mality on any of the PFS scans (p < 0.001; see Table S2).
In addition, children in the nonfebrile CSE group were far
more likely to be on antiepileptic medication at the time of
assessment, with only one child from the PFS group being
on medication at the time of our baseline assessment
(p < 0.001; see Table S3). Finally, children with nonfebrile
CSE were far more likely than children with PFS to have
experienced CSE (p = 0.001) or seizures (p = 0.003) previ-
ously. Seizures experienced by the PFS group prior to
recruitment were short febrile seizures, and only one child
had experienced a previous PFS.
Seventeen healthy controls were assessed on the Bayley’s
developmental assessment. The PFS, nonfebrile CSE and
the control groups were found to contain similar proportions
of preterms (v2 = 4.18, p = 0.354) and did not signiﬁcantly
differ on SES (F (2,67) = 0.96, p = 0.39). However, there
were fewer participants with English as their ﬁrst language
(v2 = 18.62, p < 0.001) and fewer males (v2 = 6.65,
p = 0.036) within the PFS group compared to the other two
groups.
Are the patient groups different from controls?
The PCA on the cognitive, language, and motor compos-
ite scores extracted one factor, which accounted for 83.25%
of the total variance. The univariate ANOVA revealed main
effects of group (F (2,68) = 6.524, p = 0.003), age
(F (1,68) = 9.294, p = 0.004), and prematurity (F (1,68)
= 9.167, p = 0.004). Post hoc tests with Bonferroni correc-
tion for multiple comparisons revealed that both the nonfe-
brile CSE group (p = 0.001) and the PFS group (p = 0.002)
performed below normal controls. In addition, the nonfe-
brile CSE group performed below the PFS group
(p = 0.002). In addition, we investigated whether the
patients’ scores differed from the normative mean for the
Bayley’s scales and confirmed the above results (Fig. 1).
In addition, both healthy twins outperformed their PFS
siblings. One of the healthy twins performed better on all
areas. The second healthy twin performed better in cogni-
tive and motor scales but on a par with her PFS twin on the
language scale. The difference in performance ranged from
3 to 25 points and was most pronounced in the cognitive
scale (see Table S4).
Pearson’s correlations revealed a positive correlation
between age and language performance in the PFS
(r = 0.572, p = 0.003) and the control (r = 0.647,
p = 0.005) groups. No other areas of performance were
found to be affected by age. The relationship between age
and language performance was absent from the nonfebrile
CSE group. Because this group includes a number of cases
that scored at the bottom of the scale, such a relationship
may be harder to identify. To determine whether this was
the case we reran the correlation, excluding cases that
scored lower than a 62 on the language scale, that is, the
lowest score obtained by a PFS subject. There was still no
correlation between age and language performance in this
group (r = 0.221, p = 0.348).
Which factors affect performance at baseline following
CSE?
The univariate ANOVA with the PCA-derived factor as
the dependent variable and duration of CSE, type and focali-
ty of CSE, and days from CSE as the independent variables,
revealed the absence of an effect of seizure-related variables
Figure 1.
Mean cognitive, language, and motor composites obtained by
the three groups on the Bayley Scales of Infant Development
(3rd edition) at baseline. Normative mean of 100 is indicated in
the interrupted line. Error bars represent a 95% confidence
interval. The nonfebrile CSE group obtained significantly lower
scores from the mean on all assessed scales. The PFS group
obtained significantly lower scores from the mean on the cogni-
tive and the language scales. CTRLS performed above the nor-
mative mean on language measures. PFS, prolonged febrile
seizures; CSE, convulsive status epilepticus; CTRLS, controls.
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on performance. On the contrary, our second ANOVA,
which investigated the predictive value of neurologic abnor-
malities on performance, showed that presence of an abnor-
mality on MRI (F (2,48) = 3.489, p = 0.045), signs of
developmental problems prior to CSE (F (1,48) = 24.929,
p < 0.001), and age at assessment (F (1,48) = 6.614,
p = 0.016) were significant predictors of outcome at base-
line.
Follow-up
Thirty-eight children (70.4% of the original sample) were
seen for a follow-up assessment a mean of 12.6 months
following their baseline assessment. From the remaining
children, one died, one family moved outside the United
Kingdom, two families became noncontactable, two chil-
dren provided data that could not be converted into stan-
dardized scores, and ten families declined to participate in
the follow-up stages of this study. Two children that had
outgrown the Bayley scales at follow-up were assessed
using the Wechsler Preschool and Primary Scale of Intelli-
gence (WPPSI), which provided measures of their cognitive
(i.e., full-scale intelligence quotient [FSIQ]) and language
(i.e., verbal intelligence quotient [VIQ]) development but
not of their motor development. Given that excluding their
results made no difference to the outcome, their results were
included in the current analysis.
Twenty-two children had been classified as PFS at
baseline (81.5% of the original sample) and 16 as nonfebrile
CSE (59.6% of the original sample); 7 as RS, 4 as CER, 3 as
IER, and 2 as AS. Independent sample t-tests revealed no
differences in demographic and clinical factors between the
original and the follow-up samples. Moreover, there were
no differences in the performance of the two groups at
baseline on the cognitive, language, and motor scales, point-
ing to the representativeness of the follow-up sample. This
was true even when the PFS and the nonfebrile CSE groups
were investigated separately (Table 2).
Six of 22 children in the PFS group experienced short
febrile seizures in the follow-up period, and one child had
a PFS during that period. Fourteen of 16 children in the non-
febrile CSE group experienced seizures in the follow-up
period. Three of these were CSE episodes. Finally, one child
from the PFS group and 11 from the nonfebrile CSE group
were on medication at follow-up.
Are the groups performing differently at 1-year
follow-up?
Table 2 contains the means and standard deviations for
the group’s follow-up assessment. Paired sample t-tests
revealed no difference in performance from baseline to
follow-up for the PFS (cognition: p = 0.809; language:
p = 0.181, motor: p = 0.394) and the nonfebrile CSE
(cognition: p = 0.454; language: p = 0.444; motor:
p = 0.634) groups.
In the PFS group, cognitive scores at baseline were posi-
tively correlated with cognitive scores at follow-up
(r = 0.585, p = 0.005). The same was true of language
scores (r = 0.731, p < 0.001) and motor scores (r = 0.612,
p = 0.005). Linear regression revealed that age at the time
of follow-up (p = 0.002) as well as the baseline cognitive
(p = 0.002) and baseline language (p = 0.048) composites
were highly predictive of overall outcome (factor derived
by PCA) at 12.4 months and were able to determine 87.7%
of the total variance (F (3,15) = 28.653, p < 0.001). Simi-
larly, in the nonfebrile CSE group, baseline and follow-up
cognitive (r = 0.713, p = 0.002), language (r = 0.573,
Table 2. Clinical and demographic information for follow-up participants and nonparticipants
PFS
participants
PFS
nonparticipants
Nonfebrile
CSE participants
Nonfebrile
CSE nonparticipants
N 22 5 16 11
Male 8 1 12 6
Age at test in months (SD) 18.09 (6.8) 19.86 (8.08) 13.56 (7.99) 18.22 (11.46)
Indices of mean deprivation (SD) 32 (14.76) 18.52 (4.84) 25.55 (10.49) 24.59 (15.28)
English as a first language 8 2 11 10
Prematurity 3 1 2 4
Parental report of developmental problems prior to CSE 3 3 7 5
MRI abnormalities (major/minor/N of scans) 0 0 3/5/16 1/3/8
Antiepileptic drugs 1 0 11 8
Previous seizures 6 3 13 7
Previous CSE 0 1 6 5
Continuous CSE 12 4 10 6
Focal onset of CSE 3 1 6 1
Duration of CSE in minutes (SD) 81.95 (30.48) 86 (64.36) 72.19 (59.19) 62 (26.94)
Cognitive composite (SD) 92.05 (14.85) 95 (8.66) 76.88 (20.73) 70.91 (17.72)
Language composite (SD) 92.3 (15.82) 85.6 (17.46) 75.38 (14.84) 75.18 (27.59)
Motor composite (SD) 93.87 (13.05) 103. 8 (10.4) 80.5 (20.78) 72 (24.49)
SD, standard deviation; CSE, convulsive status epilepticus; N, number; PFS, prolonged febrile seizures; MRI, magnetic resonance imaging.
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p = 0.020), and motor (r = 0.652, p = 0.008) composites
were positively correlated. Linear regression revealed
that developmental outcome in the nonfebrile CSE group
at follow-up was predicted by the baseline cognitive com-
posite score (p < 0.001) and whether the patient was on
antiepileptic medication (p = 0.002).
Discussion
This is the first study to report on the longitudinal neuro-
psychological outcomes of infants within 6 weeks of CSE
and 1 year later. Our results show that following CSE,
infants manifest a wide range of neurodevelopmental
impairments that are present at both time points. It is impor-
tant to note that these impairments are not only confined to
the nonfebrile CSE cases, who are already associated with
neurologic abnormalities at baseline, but are extended to the
PFS cases, who perform worse than controls on the assessed
measures. No significant differences were revealed between
baseline and follow-up performance, thereby demonstrating
that within the first year post CSE, developmental outcomes
remain unchanged.
Our most unexpected finding was that children with PFS
were shown to lag developmentally behind controls. More-
over, although, the PFS group was still found to perform
within the clinically normal range, their scores were similar
to those obtained by infants born very prematurely
(<28 weeks of gestation) and/or infants of an extremely low
birth weight (<1,000 g; Anderson et al., 2010). These find-
ings were paralleled by our observations in two sets of
twins, where the affected twins had lower developmental
scores than their siblings. In a separate study, we recently
reported that children following PFS manifest recognition
memory impairments within the first year following their
seizure (Martinos et al., 2012).
A caveat to the above finding was that we present data
only on children with PFS younger than 42 months as we
wanted to use the same neuropsychological instrument for
all participants. By definition, PFS occur from the age of
6 months to the age of 72 months. Nevertheless, most PFS
occur before the age of 42 months (Chin et al., 2006) and,
in the present study, the mean age of PFS was found to be
18.4 months, which is skewed to the lower end of that age
range. The FEBSTAT study, which describes 199 cases
following PFS, stated the mean age at PFS to be 16 months,
with an interquartile range of 12–24 months (Hesdorffer
et al., 2012) Therefore, the above reports suggest that the
current findings represent most of the PFS population and
are not excluding a sizeable chunk. Moreover, in our recog-
nition memory paper where the same experimental task
could be used for the entire age range, our results were not
dependent upon the age of the child (Martinos et al., 2012).
Results in the literature are mixed with respect to the
long-term outcome of children following PFS, with some
studies reporting normal development (Nelson & Ellenberg,
1978; Verity et al., 1993, 1998; Chang et al., 2000) and
other studies reporting impairments (Schiottz-Christensen
& Bruhn, 1973; van Esch et al., 1996; K€olfen et al., 1998).
However, such discrepancies may be due to differences in
methodology and definition of normality across studies.
For example, one study of monozygotic twins discrepant
only for a history of febrile seizures found that the affected
twin had a lower IQ than the unaffected twin (Schiottz-
Christensen & Bruhn, 1973). Nevertheless, their IQ was still
within the normal range. Moreover, studies have often used
different durational cutoffs to each other, with some studies
splitting their sample population into children that have
seizures lasting less than and more than 15 min (e.g., Verity
et al., 1998; Chang et al., 2000) and other studies using the
30-min durational cutoff adopted in the current study (e.g.,
Verity et al., 1993; van Esch et al., 1996). Given indications
that seizures of the prolonged kind (>30 min) are the ones
that carry an association with mesial temporal sclerosis
(Meldrum & Brierley, 1973; Baram & Shinnar, 2001), the
present study was designed specifically to only investigate
those type of seizures. It is notable, however, that recent
evidence has revealed that expressive language deficits are
present in a subset of children following short febrile
seizures (<5 min): children with recurrent febrile seizures
(Visser et al., 2012).
There are at least three possible explanations for the
reduced performance in the PFS group. The first is that PFS
led to a brain injury that causes a cognitive lag. There is
extensive evidence from animal models that CSE can cause
injury, predominantly to the hippocampus, but also in other
brain regions (Sankar et al., 1998; Ravizza et al., 2005;
Choy et al., 2010). Moreover, long-term cognitive impair-
ments has been identified in an animal model of PFS, where
animals with previously normal brains were made to seize
under high temperature conditions (Dube et al., 2006,
2009). The second is that the factors that predispose an indi-
vidual to develop PFS may also be responsible for the
reduced performance we observed in the present study.
Hippocampal abnormalities in unaffected members of fami-
lies with a history of febrile seizures and temporal lobe epi-
lepsy provide support for the hypothesis that preexisting
abnormalities may predate the seizure (Fernandez et al.,
1998). The third option would be a combination of the
above two alternatives, whereby there is a cumulative effect
of having a brain-at-risk along with an effect of the seizure
itself. Recent animal studies support this view by showing
that experiencing seizures during early development while
having a brain with malformations of cortical development
may worsen cognitive outcomes in the short but not the
longer term (Lucas et al., 2011).
Ninety-six percent of PFS cases and 59% of nonfebrile
CSE cases were recruited into this study following their first
ever CSE, that is, prior to the potential onset of epilepsy.
This enabled us to isolate the effects of CSE from the effects
of ongoing seizures and/or medication, especially in the
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case of the PFS group. A different approach with a similar
aim was adopted by Adachi et al. (2005), who carried out
FSIQ assessments of adult patients with a diagnosis of
epilepsy at two time points and compared those who had
experienced a CSE in between assessments to those who
had not. No differences were observed between the two
groups in FSIQ, suggesting that CSE in itself was not the
critical factor influencing performance in the context of
ongoing epilepsy.
In the current study, we have shown that performance
remains unchanged in the first year post CSE. Namely,
although the majority of children in our study acquired new
skills from baseline to follow-up, their standardized scores
were similar at both time points. Moreover, we have demon-
strated that seizure-related variables such as duration were
not predictive of developmental outcomes. The latter results
are in agreement with those of a recent study that found no
statistically significant differences in cognitive and motor
development between children with febrile seizures lasting
a mean of 3.82 min and those with febrile seizures lasting a
mean of 39.82 min (Hesdorffer et al., 2011). The mean
cognitive scores reported within this study were similar to
those obtained in our study, even though the mean seizure
length of our patients was almost twice as long. Taken
together, these findings exclude the theoretical possibility
that PFS has a transient effect on performance a few weeks
onward. Namely, if seizure activity in itself affects outcome
it does so in a more permanent fashion.
It was perhaps not surprising to find that children with
previous neurologic deficits, that is, structural abnormalities
and prior developmental delay, had the worst developmen-
tal outcomes. Past reports investigating outcomes following
CSE may have failed to consider the impact of such con-
founding factors, resulting in an overestimation of the
cognitive morbidity attributed to CSE (e.g., Aicardi &
Chevrie, 1970). Therefore, in the future, it may be important
to use standardized questionnaires to query developmental
functions antedating the seizure to better represent premor-
bid intellectual abilities.
Age at testing was also identified as an important predictor
of performance. However, when we looked at each assessed
area in turn, we found that this age dependency stemmed from
a relationship between age and language performance in the
PFS and the control groups only. Obtaining the same relation-
ship within our control group points away from an insult-
related explanation of this phenomenon. Nevertheless, this is
an unexpected finding when using a standardized test, where
age has been accounted for in the process of standardization.
The lack of a relationship between age and language scores in
the higher functioning nonfebrile CSE group argues against an
administration and/or test issue. Therefore, it remains plausible
that the older children assessed in this study had better lan-
guage abilities than their younger counterparts. This possibility
does not compromise our conclusions, since this observation
wasmade for both the PFS and the control groups.
Limitations
A possible limitation of this study is that the investigated
CSE cohort may not be representative of the population as a
whole. Specifically, our cohort contains a lower proportion of
children with AS (5.6% vs. 22.6%) compared to the nonpar-
ticipating cohort. Although this is an important limitation, we
believe that it does not compromise the current results. The
inclusion of these children possibly would have widened the
performance gap between the nonfebrile CSE and the other
two groups, as the acute symptomatic group were among the
lowest performers. A second potential limitation is that only
35% of the identified sample agreed to take part in our study.
However, participants and nonparticipants did not differ on
seizure duration or any demographic variables, suggesting
that the participating sample is a good representation of the
population as a whole. Moreover, the recruited number of
participants makes this study one of the largest in the litera-
ture, taking into account that we employed standardized neu-
ropsychological and imaging measures and were able to
reassess 70.4% of our baseline cohort a year onward. Finally,
within the PFS group, there was a bigger representation of
female patients than would be expected from an epidemiolog-
ic perspective (Chin et al., 2006). Nevertheless, there were
no gender effects on performance in our group, suggesting
that PFS were not differentially affecting girls and boys at
this developmental age and, therefore, that the female skew
of our sample is not biasing our results.
Conclusions
In conclusion, the current study has shown decreased levels
of functioning in all children following CSE, including those
following PFS, who are not normally associated with neuro-
logic abnormalities prior to their episode. The finding that
these impairments are still present 1 year post CSE suggests
that the seizure itself is not having a transient effect on devel-
opmental abilities (i.e., affect performance at 6 weeks but not
at 1-year follow-up). However, the present data allow for the
possibility that CSEmay have a longer lasting impact on future
development through a more permanent reorganization of
functional networks, which may have already taken place
when we first assess these children. Further longitudinal stud-
ies incorporating rigorous neurocognitive techniques are
required to better understand this issue.
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